NeoGenomics, Inc. Executive Leadership Team
Douglas M. VanOort
Chairman of the Board of Directors and Chief Executive Officer
Mr. VanOort has served as the Chairman of the Board and Chief Executive Officer of NeoGenomics since October 28, 2009. Prior to that he served as Chairman of the Board, Executive Chairman and Interim Chief Executive Officer from March 2009 to October 2009. He has been an Operating Partner with Summer Street Capital Partners since 2004 and a Founding Partner of Conundrum Capital Partners since 2000. From 1995 to 1999, he served as the Senior Vice President Operations for Quest Diagnostics, Incorporated. During this period Quest Diagnostics grew to approximately $1.5 billion in annual revenues through both organic growth and mergers and acquisitions. From 1982 to 1995, Mr. VanOort served in various positions at Corning Incorporated and ultimately held the position of Executive Vice President and CFO of Corning Life Sciences, Inc. In 1995, Corning Incorporated spun off Corning Life Sciences, Inc. into two companies, Quest Diagnostics and Covance, Inc. Mr. VanOort serves as a member of the board of directors of several privately held companies. In addition, since 2000, Mr. VanOort is the Co-Owner of Vision Ace Hardware, LLC, a retail hardware chain. Mr. VanOort is a graduate of Bentley University.
Maher Albitar, M.D.
Chief Medical Officer and Director of Research and Development
Dr. Albitar has served as Chief Medical Officer and Director of Research and Development since January 2012. Prior to NeoGenomics Dr. Albitar served as the Medical Director of Hematopathology and Oncology and Chief of R&D for Hematopathology and Oncology, Nichols Institute, Quest Diagnostics. Prior to joining Quest Diagnostics, from 1991 to 2003, Dr. Albitar held various faculty positions at The University of Texas MD Anderson Cancer Center and rose to the position of tenured Full Professor in the Departments of Leukemia and Laboratory Medicine/pathology. He held the position of Director of Molecular Laboratory and Leukemia Section at MD Anderson Cancer Center at the time of leaving MD Anderson. Dr. Albitar was trained in Anatomic and Clinical Pathology at Brown University in Providence, RI and in Hematopathology at the University of Pennsylvania. He did 4 years post-doctoral training in Genetics at the Genetic Department and Howard Hughes Medical Institute at the University of Pennsylvania. Dr. Albitar received his medical degree in 1979 from Damascus Medical School in Damascus, Syria.
George A. Cardoza
Chief Financial Officer
Mr. Cardoza has served as Chief Financial Officer of NeoGenomics since November 2009. Prior to that, from March 2008 to November 2009, Mr. Cardoza served as the Chief Financial Officer of Protocol Global Solutions, Inc., a privately held international marketing company. Mr. Cardoza also served as the Controller of Protocol Global Solutions from March 2006 to March 2008. From April 1991 to March 2006, Mr. Cardoza was employed by Quest Diagnostics Inc., a diagnostic testing, information and services company, in a number of positions, including the position of Controller – Central Region from 2001 to March 2006. At Quest Diagnostics Inc., Mr. Cardoza was responsible for overseeing all the financial operations of the Central Region, which had revenue of over $1.2 billion in 2006. Prior to his time with Quest Diagnostics Inc., he worked for Sony Music Entertainment Inc. and the Continental Grain Company in various financial roles. Mr. Cardoza received his B.S. from Syracuse University in finance and accounting and has received his M.B.A. from Michigan State University.
Steven G. Brodie, Ph.D., FACMG
Chief Scientific Officer
Dr. Brodie is the Director of Molecular Genetics and Cytogenetics at NeoGenomics Laboratories, Fort Myers, FL. Prior to joining NeoGenomics in 2011, Dr. Brodie served as Senior Director of Cytogenetics, Assistant Director of Molecular Genetics, and Scientific Director of Maternal Serum Screening at Specialty Laboratories/Quest Diagnostics in Valencia Ca. Dr. Brodie trained Pathology residents in genetic testing at both Loma Linda University Medical Center where he served as the Affiliate Rotation Director and University of Southern California, Keck School of Medicine where he served as a Clinical Assistant Professor of Pathology. Prior to joining Quest Diagnostics, he held a variety of research and clinical positions at the National Institutes of Health, University of New Mexico school of Medicine, and UCLA David Geffen School of Medicine. Dr. Brodie received his genetics training at the UCLA/Cedar-Sinai Medical Center medical genetics training program in Los Angeles Ca. He received his Ph.D. from UNM School of Medicine and completed Clinical Genetics training in Cytogenetics and Molecular Genetics at UCLA. Dr. Brodie is Board Certified by the American Board of Medical Genetics in these specialties and holds Directors Licenses in the States of Florida, California, and New York. Throughout his career, Dr. Brodie has held various research and clinical positions at the NIH, UNM and UCLA, and comes to us after directing high through put testing in Cytogenetics, FISH, Molecular Genetics and Oncology for Quest Diagnostics, Nichols Institute. He is also a CAP approved inspector.
Steven A. Ross
Chief Information Officer
Mr. Ross has served as Chief Information Officer of NeoGenomics since April 2013. Mr. Ross brings over 25 years of Technology leadership experience while most recently serving from 2003 to 2013, as the Vice President of Technology for Chico’s FAS, Inc. Chico’s is a multi-branded retailer, with over 1250 stores, an award winning eCommerce and Direct to consumer offering, and in excess of $2.5 billion in annual revenue. In addition to retail Mr. Ross has extensive Technology experience in the manufacturing, engineering, and financial sectors having served in a variety of management and consulting roles with Motorola, Directv, American Express, and Target. Mr. Ross has a Bachelor of Science Degree from New Mexico State University.
Robert J. Shovlin
Chief Operating Officer
Mr. Shovlin has served as the Chief Operating Officer of NeoGenomics since October 2014. Prior to that, from 2012 until 2014, Mr. Shovlin served as Chief Development Officer for Bostwick Laboratories, a leading provider of Anatomic Pathology testing services targeting urologists, gynecologists and other clinicians, where he was responsible for Sales, Marketing, Managed Care, Business Development, New Product Development and Clinical Trials. From 2005 until 2011, he served in several positions of increasing responsibility, including Chief Operating Officer and ultimately, President and Chief Executive Officer, for Aureon Biosciences, Inc., a venture-backed diagnostics company focused on developing novel and proprietary prostate cancer tests. Mr. Shovlin also served as Executive Director of Anatomic Pathology and Director of Managed Care for Quest Diagnostics from 2003 until 2005, and held sales leadership positions at Dianon Systems from 1997 until 2003. Mr. Shovlin served as a Captain, Infantry Officer, in the United States Marine Corps from 1992 until 1997 where he served as a Platoon Commander and Company Commander with 1st Battalion 4th Marines and as an Instructor and Staff Platoon Commander at The Basic School. He holds a Bachelor of Science Degree from Pennsylvania State University, and a Masters of Business Administration in Finance from Rutgers University.
Steven C. Jones
Executive Vice President Finance, Chief Compliance Officer, Board Member
Mr. Jones has served as a director of NeoGenomics since October 2003, as Executive Vice President of Finance since November 30, 2009, and as Chief Compliance Officer since February 7, 2013. Mr. Jones served as Chief Financial Officer of the Company from October 2003 until November 30, 2009. He is a Managing Director in Medical Venture Partners, LLC, a venture capital firm established in 2003 for the purpose of making investments in the healthcare industry. Mr. Jones is also the founder and Chairman of the Aspen Capital Group and has been President and Managing Director of Aspen Capital Advisors since January 2001. Prior to that Mr. Jones was a chief financial officer at various public and private companies and was a Vice President in the Investment Banking Group at Merrill Lynch & Co. Mr. Jones received his B.S. degree in Computer Engineering from the University of Michigan in 1985 and his MBA degree from the Wharton School of the University of Pennsylvania in 1991. He also serves as Chairman of the Board of T3 Communications, Inc. and Chairman of the Board of SpinaDyne, Inc.
Robert H. Horel
Vice President and General Manager of Path Logic
Mr. Horel has served as Vice President and General Manager of Path Logic since October of 2014. Prior to that, he served as Vice President of Sales and Marketing from May 2011 – a period during which NeoGenomics emerged as the fastest growing laboratory in the country for three consecutive years. Mr. Horel joined NeoGenomics in December 2006 and served as the Regional Sales Director for NeoGenomics’ Southeastern Region up to the time of his appointment as Vice President. Prior to joining NeoGenomics, Mr. Horel held sales and marketing positions of increasing prominence with Ventana Medical Systems (a developer, manufacturer and marketer of certain medical tests and instruments), US Labs (an anatomic pathology and genetic testing laboratory), and Radiometer America (a medical testing and instrumentation division of Danaher). Mr. Horel graduated from the United States Naval Academy in 1987, earning a Bachelor of Science Degree with Distinction in Mechanical Engineering, and he served as a pilot in the US Navy before beginning his business career in 1998.
Director of Finance and Principal Accounting Officer
Mr. Weidig III has served as Director of Finance and Principal Accounting Officer since January 2012. Mr. Weidig served as the Company’s Corporate Controller from October 2007 until January 2012. Prior to that, from May 2005 to October 2007 he was a Division Controller for Meritage Homes Corporation (NYSE:MTH) in Fort Myers, Florida, and prior to that from January 1999 to May 2005 he worked in public accounting for a local firm in Fort Myers Florida and for the PricewaterhouseCoopers office in Boston, Massachusetts. Mr. Weidig earned his Bachelor of Science degree in Business Administration from Merrimack College. Mr. Weidig holds an active CPA license with the state of Massachusetts.